# 95% of Healthcare Professionals Surveyed Support Legal Medical Marijuana, 74% Open to … > **Author:** Benjamin Caplan, MD (ABFM Board Certified, MA Lic. #240562, NPI: 1962722637) > **Publisher:** CED Clinic (https://cedclinic.com) > **Canonical URL:** https://cedclinic.com/95-of-healthcare-professionals-surveyed-support-legal-medical-marijuana-74-open-to/ > **Published:** 2026-07-14T17:14:31-04:00 | **Last Modified / Clinically Audited:** 2026-09-09T10:00:09-04:00 > **Clinical Summary:** Healthcare professionals cannabis medicine support reaches 95% in Johns Hopkins survey. What this means for clinical practice and patient access. --- ✦ New CED Clinical Relevance #77 Strong Clinical Relevance High-quality evidence with meaningful patient or clinical significance. PolicyResearchMental HealthPainSafetyAnxietyDosing Why This Matters Healthcare professionals’ growing support for medical [cannabis legalization](https://cedclinic.com/the-forgotten-history-of-hemp-in-america/) may encourage clinical institutions to develop evidence-based cannabis counseling protocols and integrate cannabis-drug interaction screening into patient care. This shift in professional opinion could reduce stigma around cannabis discussions in clinical settings, allowing patients to disclose their use more openly and enabling clinicians to provide better-informed harm reduction guidance. The 74% openness to [cannabis research](https://cedclinic.com/pediatric-cannabis-certification-care-children/) suggests momentum toward generating the clinical evidence needed to establish dosing standards, efficacy data, and safety profiles for specific conditions. Clinical Summary A survey of 879 healthcare professionals from Johns Hopkins University School of Medicine and Baylor College of Medicine found overwhelming support for [medical cannabis](https://cedclinic.com/therapeutic-benefits-of-thc/) legalization, with 95% of respondents endorsing legal access and 74% open to [cannabis research](https://cedclinic.com/pediatric-cannabis-certification-care-children/) participation. This high degree of professional endorsement reflects a significant shift in clinician attitudes toward cannabis therapeutics and suggests growing recognition of potential clinical applications within the medical community. The broad support among healthcare providers indicates a disconnect between professional opinion and regulatory restrictions that remain in many jurisdictions, potentially limiting patient access to a treatment modality that most clinicians view as legitimate. These findings underscore the clinical profession’s readiness to engage with cannabis science and may accelerate the evidence-building process needed to establish efficacy and safety profiles for specific conditions. For clinicians, this survey validates that interest in [cannabis medicine](https://cedclinic.com/essential-oils-industrial-hemp-antimicrobial-benefits/) is professionally mainstream, while for patients, it signals that physician skepticism may be less of a barrier than regulatory and legal constraints to accessing cannabis-based care. Dr. Caplan’s Take “This survey reflects a meaningful shift in professional attitudes, but I’d emphasize that provider support for legalization doesn’t automatically translate to robust clinical evidence in any given condition—we still need rigorous, well-designed trials to understand where cannabis fits responsibly in our treatment algorithms.” Clinical Perspective 💊 While this survey documenting broad healthcare professional support for medical [cannabis legalization](https://cedclinic.com/the-forgotten-history-of-hemp-in-america/) and research reflects shifting attitudes within medicine, clinicians should recognize that survey responses about policy positions do not necessarily translate into clinical confidence or evidence-based prescribing practices. The disconnect between expressed support for legalization and actual comfort with [clinical cannabis](https://cedclinic.com/entourage-effect-cannabis-clinical-breeding-benefits/) use is notable, and many providers who endorse research availability may still lack the training, evidence base, and regulatory frameworks needed to counsel patients effectively on cannabis as a therapeutic option. Key confounders include variable definitions of “medical marijuana” across respondents, regional differences in state-level regulations, and the reality that professional support for research does not equate to robust clinical trial data for most cannabis indications. For practicing clinicians, this survey suggests growing professional openness to cannabis integration in healthcare, but the practical implication is that providers should not assume colleague support translates to established clinical protocols or high-quality evidence for patient conversations, and instead should seek out 💬 Join the Conversation Have a question about how this applies to your situation? [Ask Dr. Caplan →](https://benjamincaplan.com/ask-dr-caplan) Want to discuss this topic with other patients and caregivers? [Join the forum discussion →](https://cedclinic.com/interact/discussion-forums/) Have thoughts on this? Share it: [X Share on X](https://twitter.com/intent/tweet?text=Just%20read%20this%20on%20CEDclinic.com%3A%2095%25%20of%20Healthcare%20Professionals%20Surveyed%20Support%20Legal%20Medical%20Marijuana%2C%2074%25%20Open%20to%20...%20%40drcaplan&url=https%3A%2F%2Fcedclinic.com%2F%3Fp%3D69641)[in Share on LinkedIn](https://www.linkedin.com/sharing/share-offsite/?url=https%3A%2F%2Fcedclinic.com%2F%3Fp%3D69641)[🦅 Share on BlueSky](https://bsky.app/intent/compose?text=Just%20read%20this%3A%2095%25%20of%20Healthcare%20Professionals%20Surveyed%20Support%20Legal%20Medical%20Marijuana%2C%2074%25%20Open%20to%20...%20via%20%40drcaplan.bsky.social%20https%3A%2F%2Fcedclinic.com%2F%3Fp%3D69641)[📷 Follow on Instagram](https://www.instagram.com/drbenjamincaplan)[📝 Read more on Substack](https://doctorapprovedcannabis.substack.com/)[🔔 Subscribe via RSS](https://cedclinic.com/feed/) Related Articles - [Surveyed Cancer Patients Worry About Cannabis Access Barriers](https://cedclinic.com/cannabis-access-barriers-cancer-symptom-management/) - [New ADAI Research: Cannabis-Related Problems and Clinical Experiences](https://cedclinic.com/cannabis-use-disorder-clinical-education-insights/) - [In the Mix: Cannabis Market Trends and Articles — March 04, 2026](https://cedclinic.com/cannabis-market-trends-2026-march-04/) 📰 Source: [https://themarijuanaherald.com/2026/07/95-of-healthcare-professionals-surveyed-support-legal-medical-marijuana-74-open-to-recommending-it/](https://themarijuanaherald.com/2026/07/95-of-healthcare-professionals-surveyed-support-legal-medical-marijuana-74-open-to-recommending-it/) Further Reading CED Clinic Blog[Why Cannabis Works](https://cedclinic.com/why-cannabis-works/) Evidence Watch[Cannabis and Heart Health](https://cedclinic.com/cannabis-cardiovascular-health-study/) CED Clinic Blog[Cannabis for Sleep](https://cedclinic.com/cannabis-for-sleep/) [https://cedclinic.com/contact/](https://cedclinic.com/contact/) Physician-Led, Whole-Person Care A doctor who takes the time to truly understand you. Personal care that starts with listening and is guided by experience and ingenuity. Health, Longevity, Wellness One-on-One Cannabis Guidance Metabolic Balance [Leave a Message](https://cedclinic.com/contact/) [Metabolic Care](https://cedclinic.com/metabolic/metabolic-how-it-works/) [Medical Consulting](https://cedclinic.com/book/) [Cannabis Care](https://cedclinic.com/book/) [https://cedclinic.com/contact/](https://cedclinic.com/contact/) ### Related --- ### Verification & Medical Governance - **Lead Clinical Author:** Benjamin Caplan, MD - **Credentials:** Board Certified in Family Medicine (ABFM), Former CMO Canna Care Docs (250,000+ patients supervised), Founder & CMO CED Clinic & CED Foundation, Author of *The Doctor-Approved Cannabis Handbook* (Penguin Random House). - **Clinical Scale:** 350,000+ lifetime evaluations overseen; 81,008-patient Real-World Evidence Registry (`~/.ced_rwe_vault.db`); 125,000+ peer-reviewed study literature observatory (`http://localhost:8768/api/explorer/terminal`). - **License Verification:** Commonwealth of Massachusetts License #240562 (https://checkahealthlicense.mass.gov/). - **NPI Registry:** 1962722637 (https://npiregistry.cms.hhs.gov/provider-view/1962722637). - **Ethics & Data Privacy:** Clinical registry observations adhere strictly to HIPAA Safe Harbor de-identification (45 CFR § 164.514(b)) and criteria for secondary research exemption under 45 CFR § 46.104(d)(4).